← Evidence map

ReviewFrontiers in pharmacology2021

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update.

Hrvoje Roguljic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

25 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34045969